Fresenius seeks more time to sell its Dabur shares - Livemint PDF Print

Mumbai: Fresenius Kabi (Singapore) Pte Ltd, the majority stake holder in the Indian cancer specialty drug maker Dabur Pharma Ltd, has asked for more time ...

read more

 
Share |
Copyright © 2017 Global Dialysis. All Rights Reserved.